Immunity meetings & conferences

The Immunology of a Successful Pregnancy

Wednesday, 16 October 2013 09:00 - 17:00 London, United Kingdom

'This event will challenge scientists and clinicians interested in the field of reproductive immunology to evaluate many of the 'classical concepts' associated with pregnancy immunology. This event aims to define new approaches to allow a better understanding of immunity during pregnancy that will benefit mothers and foetuses in different clinical scenarios'

This event  has CPD accreditation and is part of the 2013 Pregnancy Summit - www.PregnancySummit2013.com

Who Should Attend

Biotech and Pharma Industry Managers: CEOs, Chief Scientists, Group Heads, Senior and Junior Scientists, Research working in the field of immunology and pregnancy

Academic and Research Institutes: Group and Lab Heads, Postdoctoral Scientists and Research Students working in the field of immunology and pregnancy

Clinicians: Anyone working in the field of pregnancy and diagnosing pregnancy-related illnesses and pregnancy outcome

Contact Details

Email: enquiries@euroscicon.com

Web: www.lifescienceevents.com

International Society for Exercise Immunology Symposium 2013

9-12 September 2013 Newcastle, Australia

The ISEI 2013 Symposium will be held in Newcastle, Australia from 9-12 September 2013. The theme of the symposium is: Exercise Immunology: Prescriptions for Health. International invited speakers will address the role of exercise, nutrition and immune protection on respiratory, gut, mental health and provide advice for exercise in children and ageing populations.

8th Invest in ME International ME (ME/CFS) Conference 2013 Infection, Immunity and Myalgic Encephalomyelitis - Mainstreaming ME ResearchClinical and Research Updates

IIMEC8 - 31st May 2013 Westminster, London, United Kingdom

Research into Myalgic Encephalomyelitis - specifically biomedical research into ME – has been receiving increasingly more attention from both major research institutes in several countries as well as national health organisations. The Medical Research Council (MRC) in the UK, the Food & Drug Administration and Centres for Disease Control and Prevention in USA have created initiatives for new biomedical research into ME. In Norway the Norwegian Health Directorate have allocated funding for biomedical research into ME following the 2011 double blind randomised clinical trial using Rituximab (Anti-CD20 monoclonal antibody) by Fluge et al (PLoS 6:10.Oct 2011) to successfully treat ME patients.

There is increasing research evidence of immune dysfunction in ME patients.

The UK MRC states -

“There is now preliminary evidence supporting the view that inflammatory mechanisms in the brain and spinal cord may underlie the pathophysiology of some severe disease CFS/ME phenotypes. Biobanks are now becoming available and create a unique opportunity for interrogation.” 

The IIMEC8 conference will show some of the major initiatives being taken to set up a collaborative strategy for biomedical research into ME to further this complex but exciting area of research leading to appropriate patient care and mainstreaming this field of research as well as this disease.

2nd Li Ka Shing Institute of Virology Symposium: Interactions Between the Immune System and Pathogens

May 30 & 31, 2013 Edmonton, Alberta, Canada

Symposium with national and international Speakers in the field of virology. Two-day conference with ample opportunity for networking and a large poster session.

Options for the Control of Influenza VIII

September 5-10, 2013 Cape Town, South Africa

Held every 3 years, Options for the Control of Influenza is the largest international scientific conference exclusively devoted to influenza.  Options VIII will showcase recent advances in the basic science and control and prevention of influenza.  Whatever your domain of expertise – virology, veterinary medicine, human medicine, public health policy, industry or journalism – Options for the Control of Influenza VIII is the premier conference bringing together experts dedicated to all aspects of influenza.  Presentation formats will include keynote addresses, invited lectures, scientific workshops, abstract presentations, satellite meetings and poster sessions.

The 2013 conference will allow delegates to experience the beauty and warm hospitality of Cape Town, South Africa. Delegates at Options VIII will experience an unforgettable mix of modern and traditional African ambience. Options VIII will highlight these characteristics along with cultural events strategically placed within the agenda. In addition, delegates will be provided an opportunity to participate in many pre-conference or post-conference tours on their own to encounter nature and history and create memories to treasure.

Conference Goals and Objectives:

•Provide comprehensive scientific guidance for all stakeholders involved in influenza prevention, control, and treatment, including seasonal pandemic planning

•Promote genuine international and multidisciplinary collaboration, supporting the full spectrum of influenza research from basic science to the development of new vaccines and antiviral agents to epidemiology and control programs

•Provide a collegial atmosphere where scientists working in public health and scientists working in agricultural or veterinary agencies may exchange information to develop collaborative approaches to the control and prevention of pandemic influenza

•Maximize the opportunities for informal discussions and exchange of ideas between representatives of government agencies, academia, and industry

Join us in Cape Town and experience this premier event!

For questions contact us at info@controlinfluenza.com.

16th International Congress of Mucosal Immunology (ICMI 2013)

July 17-20, 2013 Vancouver, British Columbia, Canada

The 16th International Congress of Mucosal Immunology (ICMI 2013) is widely recognized as the pre-eminent conference on mucosal immunology, combining high-quality basic science with the clinical situation. ICMI 2013 is the only meeting where basic scientists, clinical researchers and industry professionals working at mucosal surfaces can meet to discuss the common and unique pathways of immunity and inflammation at different sites in the body.

FOCIS 2013

Thursday, June 27 through Sunday, June 30, 2013 Boston, Massachusetts

FOCIS is the meeting in translational immunology that will give you a competitive edge in your career. Stay ahead of the curve with leading clinicians and researchers delivering the latest breakthroughs across immune-mediated diseases. Focusing on molecular pathways and their implications in human disease provides the unique opportunity for innovative thinking and apply ideas from the pathologies of other diseases to uncover novel solutions to challenges in the diseases you study. 

World-renowned speakers explore their work and touch on the FOCIS themes of: Immunoregulation, Immunodiagnosis, Immunogenetics, Immunotherapy and Host Defense. FOCIS has grown to 53 Member Societies that collectively represent over 65,000 basic and clinician scientists. The FOCIS meeting brings together these researchers and clinicians working in more than 30 clinical specialties and provides them with a forum to gather and share the latest findings, breakthroughs and therapies related to human disease. The FOCIS concept posits that interrelationships between fields sharing clinical immunology expertise will build a better and faster pathway to improve knowledge that leads to new therapies for inflammatory and immunologic diseases.
 

The 2013 Three Rs Event: Toll Like Receptors (TLRs), RIG-Like Receptors (RLRs) and Nod-Like Receptors (NLR)

Thursday, 19 September 2013 09:00 - 09:00 London, United Kingdom

The aim of this meeting is to provide an overview of these three families of receptors and provide the most recent advances in the area of innate immune pattern recognition

Contact Details

Email: enquiries@euroscicon.com

Web: www.lifescienceevents.com

Phone:  07507 799380